Introducing Continuous Infection Monitoring (CIM) Technology
The only medical device that detects and alerts of infection in real-time
An Entrepreneurial Student-led Initiative
BioAlert Technologies is on a mission to develop methodologies that detect infection in real-time. We are a development stage medical device company dedicated to the design and production of continuous infection monitoring (CIM) systems for diabetic foot ulcer patients. BioAlert Technologies enables healthcare providers to make diagnosis and treatment decisions utilizing reliable data metrics.
Our product features a user-friendly, dual-platform software solution. We enable patients to be notified of an infection through a mobile app on their IOS or Android Device and provide physicians with a detailed bacterial analysis which allows them to make more informed clinical decisions.
With our solution, we can eliminate the higher cost associated with serious complications due to infection and improve the quality of life for all of our target patients.
Early Detection Alert
Our proprietary technology provides value to all key stakeholders in the healthcare system. We allow patients to go about their lives worry-free while we provide 24/7 monitoring which notifies patients upon infection.
Advisors: Alexander Cameron, Dr. David Armstrong, Dr. Francis Barany, Dr. Thomas Schaer, Dr. Vaishali Inamdar,
Inspired by Grandfather, Philadelphia-Based Entrepreneur Plans to Disrupt The Infection Control Industry
The seeds of groundbreaking infection monitoring technology were sown years ago, by the hospital bedside of founder Marc Rosenberg's grandfather. ...
Team Spotlight: Soleil Valentin
Given the collaborative nature of the startup world, a new company is only as great as the sum of its parts. ...